HeartMate II Left Ventricular Assist System (LVAS)
ABBOTT MEDICAL · Decision date Jun 10, 2026
What did the FDA approve?
FDA records P060040/S124 as a supplement to PMA P060040, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Jun 10, 2026.
FDA approval order statement
Approval for alternate connector components for the connection interface between the user interface (UI) membrane and the main printed circuit board assembly (PCBA) of the HeartMate II (HMII) System Controller and HeartMate 3 (HM3) System Controller.
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Jun 10, 2026
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P060040/S124
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- DSQ
- Decision code
- APPR
- Decision date
- Jun 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ventricular (assist) bypass.
- Applicant
- Abbott Medical
- Product code
- DSQ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P060040. Subsequent supplements may change the device or its indications.
FDA decision timeline
P060040 · Original PMA
THORATEC HEARTMATE II LEFT VENTRICULAR ASSIST SYSTEM
P060040/S120 · Related supplement
HeartMate II Left Ventricular Assist System
P060040/S112 · Related supplement
HeartMate Apical Coring Knife
P060040/S122 · Related supplement
HeartMate II Left Ventricular Assist System
P060040/S121 · Related supplement
HeartMate II Left Ventricular Assist System (LVAS)
P060040/S124 received
Application receipt date recorded by FDA.
P060040/S123 · Related supplement
HeartMate II Left Ventricular Assist System
P060040/S124 · FDA decision
Real-Time Process
P060040/S125 · Related supplement
HeartMate II Left Ventricular Assist System
P060040/S126 · Related supplement
HeartMate II Left Ventricular Assist System
P060040/S128 · Related supplement
HeartMate II LVAS
Timeline entries are records held by MedtechLedger for P060040. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P060040
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA approval | Apr 21, 2008 | FDA | |
HeartMate II Left Ventricular Assist SystemP060040/S120 | ABBOTT MEDICAL | PMA supplement | Jul 17, 2025 | FDA |
HeartMate Apical Coring KnifeP060040/S112 | ABBOTT MEDICAL | PMA supplement | Oct 17, 2025 | FDA |
HeartMate II Left Ventricular Assist SystemP060040/S122 | ABBOTT MEDICAL | PMA supplement | Dec 17, 2025 | FDA |
| ABBOTT MEDICAL | PMA supplement | Feb 18, 2026 | FDA | |
HeartMate II Left Ventricular Assist SystemP060040/S123 | ABBOTT MEDICAL | PMA supplement | May 29, 2026 | FDA |
HeartMate II Left Ventricular Assist SystemP060040/S125 | ABBOTT MEDICAL | PMA supplement | Jul 9, 2026 | FDA |
HeartMate II Left Ventricular Assist SystemP060040/S126 | ABBOTT MEDICAL | PMA supplement | Aug 12, 2026 | FDA |
HeartMate II LVASP060040/S128 | ABBOTT MEDICAL | PMA supplement | Oct 1, 2026 | FDA |
Explore the linked device profile
Other records with product code DSQ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EXCOR Pediatric Ventricular Assist DeviceP160035/S054 | Berlin Heart, Inc. | PMA supplement | Oct 30, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S034 | Abbott | PMA supplement | Oct 30, 2026 | FDA |
EXCOR Pediatric VADP160035/S061 | Berlin Heart, Inc. | PMA supplement | Oct 28, 2026 | FDA |
EXCOR Pediatric Ventricular Assist DeviceP160035/S060 | Berlin Heart, Inc. | PMA supplement | Oct 23, 2026 | FDA |
HeartMate 3 Left Ventricular Assist SystemP160054/S136 | ABBOTT MEDICAL | PMA supplement | Oct 19, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 6035 Stoneridge Dr., Pleasanton, CA, 94588
Sources and methodology
- Original FDA record: P060040/S124
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





